T1 Biomarker 1116 1140 small-molecule inhibitor
T2 Condition 1424 1436 glioblastoma
T3 Organism 883 893 Drosophila
T4 Protein 393 398 FOXD1
T5 Gene 862 879 orthologous genes
T6 Condition 1283 1295 glioblastoma
T7 Protein 34 50 tumor-initiating
T8 Condition 172 175 GSC
T9 CL 201 213 mesenchymal 
T10 Condition 914 926 brain tumors
T12 Protein 1032 1037 FOXD1
T13 Protein 302 309 ALDH1A3
T14 Protein 627 632 FOXD1
T15 Protein 772 779 ALDH1A3
T16 Intervention 967 976 specimens
T17 Protein 1413 1420 MES GSC
T18 Condition 24 27 GSC
T19 Protein 349 356 MES GSC
T20 Protein 721 728 MES GSC
T22 CL 218 263  GSC population as the more malignant subtype
T23 CL 348 353  MES 
T24 CL 1412 1417  MES 
T25 Condition 725 728 GSC
T26 Protein 513 527 shRNA-mediated
T27 Protein 552 555 MES
T28 Protein 1042 1049 ALDH1A3
T29 Protein 552 559 MES GSC
T30 Level 429 436 patient
T31 Level 1080 1087 patient
T32 Protein 214 217 MES
T34 Condition 219 222 GSC
T35 Condition 980 997 high-grade glioma
T36 Condition 1424 1443 glioblastoma tumors
T37 Level 76 84 cellular
T38 Protein 296 301 FOXD1
T39 CL 551 556  MES 
T41 CL 720 725  MES 
T42 Protein 721 724 MES
T43 Protein 1333 1346 FOXD1–ALDH1A3
T44 Protein 1413 1416 MES
T45 Protein 543 548 FOXD1
T46 Condition 98 110 glioblastoma
T47 Protein 1333 1338 FOXD1
T48 Protein 1358 1372 controling the
T49 Protein 675 682 ALDH1A3
T50 Protein 349 352 MES
T51 Protein 468 471 MES
T52 Condition 500 503 GSC
T53 Condition 1245 1273 murine GSC-derived xenograft
T54 Protein 296 309 FOXD1–ALDH1A3
T57 Protein 762 767 FOXD1
